BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8785966)

  • 1. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of an enzyme-linked immunosorbent assay for potency testing of erysipelas bacterins.
    Henderson LM; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():333. PubMed ID: 8785973
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
    Henderson LM; Jenkins PS; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
    [No Abstract]   [Full Text] [Related]  

  • 4. General information about the validation of serological method (ELISA) for the batch potency testing erysipelas vaccines.
    Altern Lab Anim; 2002; 30(5):486-7. PubMed ID: 12434771
    [No Abstract]   [Full Text] [Related]  

  • 5. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
    Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
    ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
    Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Leptospira pomona ELISA and its correlation with the hamster potency assay.
    Ruby KW
    Dev Biol Stand; 1996; 86():340. PubMed ID: 8785980
    [No Abstract]   [Full Text] [Related]  

  • 8. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
    Cussler K; Balks E
    ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vitro assay for measuring the relative potency of leptospiral bacterins containing serovar canicola and its correlation to the hamster potency assay.
    Ruby KW; Walden DM; Wannemuehler MJ
    Dev Biol Stand; 1996; 86():341. PubMed ID: 8785981
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 11. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test.
    Rosskopf-Streicher U; Johannes S; Wilhelm M; Cussler K
    Vaccine; 2001 Jan; 19(11-12):1477-83. PubMed ID: 11163671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies of the standardization of erysipeloid immune sera "Dessau" from swine using the mouse-protection test and ELISA].
    Dahms H; Hagemann G; Hlinak A
    Zentralbl Veterinarmed B; 1991 Oct; 38(8):581-8. PubMed ID: 1789015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of Erysipelothrix rhusiopathiae specific antibodies in the serum of experimentally-infected swine by ELISA and immunoblotting].
    Dahms H; Schilow WF; Hagemann G
    Arch Exp Veterinarmed; 1989 Nov; 43(6):907-16. PubMed ID: 2619491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the protective antigen of Erysipelothrix rhusiopathiae in the enzyme-linked immunosorbent assay and latex agglutination.
    Sato H; Yamazaki Y; Tsuchiya K; Aoyama T; Akaba N; Suzuki T; Yokoyama A; Saito H; Maehara N
    Zentralbl Veterinarmed B; 1998 Sep; 45(7):407-20. PubMed ID: 9780828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector.
    Ogawa Y; Oishi E; Muneta Y; Sano A; Hikono H; Shibahara T; Yagi Y; Shimoji Y
    Vaccine; 2009 Jul; 27(33):4543-50. PubMed ID: 19433128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective antigens of the swine erysipelas bacterium (Erysipelothrix rhusiopathiae. 1. Specific demonstration of the protective antigen].
    Rothe F
    Arch Exp Veterinarmed; 1982; 36(2):243-53. PubMed ID: 6808965
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of rocket immuno-electrophoresis (RIE) and ELISA for determination of tetanus antibodies in tetanus immunoglobulins.
    Zott A
    Dev Biol Stand; 1996; 86():348. PubMed ID: 8785988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.